Carnitine acylcarnitine translocase deficiency: genes and variants
Explore variant evidence for Carnitine acylcarnitine translocase deficiency across 1 analyzed protein (SLC25A20). Linked ClinVar records include 9 pathogenic or likely pathogenic variants, 57 variants of uncertain significance and 6 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-10-15. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Carnitine acylcarnitine translocase deficiency
SLC25A20: Mitochondrial carnitine/acylcarnitine carrier protein
It exchanges acylcarnitines and free carnitine across the inner mitochondrial membrane, allowing long-chain fatty acids to enter the beta-oxidation pathway. Biallelic loss-of-function variants cause carnitine-acylcarnitine translocase deficiency, often with severe neonatal hypoglycemia, hyperammonemia, and cardiomyopathy.
9 ClinVar pathogenic / likely pathogenic and 63 uncertain variants in SLC25A20 have source records linked to Carnitine acylcarnitine translocase deficiency. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Carnitine acylcarnitine translocase deficiency
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| SLC25A20 D231H | 231 | Solcar 3 | Pathogenic / likely pathogenic (★★) |
| SLC25A20 R133W | 133 | Solcar 2 | Pathogenic / likely pathogenic (★★) |
| SLC25A20 R275Q | 275 | Solcar 3 | Pathogenic / likely pathogenic (★★) |
| SLC25A20 A281V | 281 | Solcar 3 | Pathogenic / likely pathogenic (★★) |
| SLC25A20 R178Q | 178 | Solcar 2 | Pathogenic / likely pathogenic (★★) |
| SLC25A20 Q238R | 238 | Solcar 3 | Pathogenic / likely pathogenic (★★) |
| SLC25A20 G81R | 81 | Solcar 1 | Pathogenic / likely pathogenic (★) |
| SLC25A20 P230R | 230 | Solcar 3 | Pathogenic / likely pathogenic (★) |
| SLC25A20 M1V | 1 | Pathogenic / likely pathogenic (★) |
Frequently asked questions
Which genes have records linked to Carnitine acylcarnitine translocase deficiency?
This view contains 1 analyzed proteins: SLC25A20. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 9 pathogenic or likely pathogenic variants, 57 variants of uncertain significance and 6 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 93 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center